Literature DB >> 8482356

Modulation of growth of vascular smooth muscle cells by activin A.

I Kojima1, H Mogami, N Kawamura, H Yasuda, H Shibata.   

Abstract

Activin A is a homodimeric protein structurally related to transforming growth factor-beta. The present study was conducted to examine the effect of activin A on the growth of rat vascular smooth muscle cells (VSMC) in culture. When serum-deprived cells were incubated with activin A, nuclear labeling of bromodeoxyuridine occurred after a 12-h lag period. The effect of activin A on nuclear labeling was dose-dependent, being maximal at 10(-9) M. Activin A also increased the number of VSMC after 30 h of incubation. Insulin-like growth factor-1 (IGF-1) had only a small effect on nuclear labeling by itself but the effects of IGF-1 and activin A were additive. When quiescent VSMC were treated with activin A for 4 h, the effect of subsequent IGF-1 was markedly enhanced. Furthermore, activin A induced an autocrine production of IGF-1 in VSMC. In contrast to these positive effects on cell growth, activin A was rather inhibitory to the action of IGF-1 in activin-primed cells. In addition, activin A inhibited platelet-derived growth factor-induced nuclear labeling. These results indicate that activin A modifies growth of VSMC by complex mechanisms involving autocrine production of IGF-1 and modification of the action of IGF-1.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8482356     DOI: 10.1006/excr.1993.1131

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  9 in total

1.  Overexpression of Smad2 drives house dust mite-mediated airway remodeling and airway hyperresponsiveness via activin and IL-25.

Authors:  Lisa G Gregory; Sara A Mathie; Simone A Walker; Sophie Pegorier; Carla P Jones; Clare M Lloyd
Journal:  Am J Respir Crit Care Med       Date:  2010-03-25       Impact factor: 21.405

2.  Tissue-specific expression of inhibin/activin subunit and follistatin mRNAs in mid- to late-gestational age human fetal testis and epididymis.

Authors:  V J Roberts
Journal:  Endocrine       Date:  1997-02       Impact factor: 3.633

3.  Expression of immunoreactive activin A protein in remodeling lesions associated with interstitial pulmonary fibrosis.

Authors:  T Matsuse; A Ikegami; E Ohga; T Hosoi; T Oka; K Kida; M Fukayama; S Inoue; T Nagase; Y Ouchi; Y Fukuchi
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

Review 4.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part III. Proliferation in normal, injured and diseased tissue, growth factors, differentiation, DNA replication sites and in situ hybridization.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1996-08

5.  Stimulation of activin A expression in rat aortic smooth muscle cells by thrombin and angiotensin II correlates with neointimal formation in vivo.

Authors:  J E Pawlowski; D S Taylor; M Valentine; M E Hail; P Ferrer; M C Kowala; C J Molloy
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

6.  Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2.

Authors:  T Nakaoka; K Gonda; T Ogita; Y Otawara-Hamamoto; F Okabe; Y Kira; K Harii; K Miyazono; Y Takuwa; T Fujita
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

7.  Enhancement by tocoretinate of epidermal growth factor-induced DNA synthesis in human intestinal epithelial cells.

Authors:  N Kawamura; K Miki; K Kurokawa; I Kojima
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

8.  Production of activin A in human intestinal epithelial cell line.

Authors:  N Kawamura; R Nobusawa; H Mashima; M Kanzaki; H Shibata; I Kojima
Journal:  Dig Dis Sci       Date:  1995-10       Impact factor: 3.199

9.  Localization of follistatin, an activin-binding protein, in bone tissues.

Authors:  S Inoue; S Nomura; T Hosoi; Y Ouchi; H Orimo; M Muramatsu
Journal:  Calcif Tissue Int       Date:  1994-11       Impact factor: 4.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.